Signal FDA removes the testosterone cardiovascular black box warning in February 2025
Summary
The Initiative reports that the largest randomized trial of testosterone therapy established cardiovascular safety in monitored hypogonadal men, and that in February 2025 the US Food and Drug Administration removed the cardiovascular risk black box warning from all testosterone products.
Classification
Main topicTech Regulation & Digital Policy
Region menusNorth America
Occurrencescope:country · geo_region:north_america · country:US
Impactscope:country · geo_region:north_america · country:US
Time horizon0-3 years (2026-07-26)
Last updated2026-07-29 04:49:52
Evidence 1
- Initiative Trends 2026: Collective Intelligence and Foresight from Global Wellness Leaders Global Wellness Institute page=56;section=Men's Wellbeing Initiative Trends / TREND 7: Men's Hormonal, Metabolic and Environmental Health Reaches an Inflection Point 2026-05 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-209f5ed38f44